Seattle Genetics Inc (NASDAQ:SGEN)

36.13
Delayed Data
As of Apr 17
 -0.44 / -1.20%
Today’s Change
30.05
Today|||52-Week Range
44.95
+12.45%
Year-to-Date

Today’s Trading

Previous close36.57
Today’s open36.52
Day’s range35.93 - 36.86
Volume1,180,863
Average volume (3 months)1,112,538
Market cap$4.5B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-14.72%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book21.24

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.48-1.38%
HZNPHorizon Pharma PLC-0.15-0.50%
ACADACADIA Pharmaceutica...-0.64-1.66%
RCPTReceptos Inc-0.59-0.35%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers